HCC in the second-line setting. meetinglibrary.asco.org/record/173190/…
![](https://pbs.twimg.com/media/D8HZg1xVUAAd4MF.jpg)
![](https://pbs.twimg.com/media/D8HdwYzVsAAR4h1.jpg)
![](https://pbs.twimg.com/media/D8HfBpOUEAI9BQm.jpg)
Durvalumab +/- tremelimumab in second-line metastatic head and neck cancer not better than SOC chemo (including methotrexate!). Do not use durvalumab. meetinglibrary.asco.org/record/175441/…